Sanofi and three other diabetes drugmakers are urging a federal district court to dismiss 340B antitrust allegations against them.

Diabetes Drugmakers Urge Federal Appeals Court to Dismiss Health Centers’ 340B Antitrust Lawsuit

September 17, 2024 William Newton, Associate Editor/Senior Writer Views

Four diabetes drugmakers are urging a federal appeals court to uphold a lower court’s decision to dismiss 340B antitrust claims [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!